Send to

Choose Destination
Cancer Discov. 2019 Oct;9(10):OF8. doi: 10.1158/2159-8290.CD-RW2019-125. Epub 2019 Aug 16.

Deglycation of NRF2 by FN3K Promotes Oncogenesis and Drug Resistance.

[No authors listed]


Fructosamine-3-kinase (FN3K) activity promotes oncogenesis in models of liver and lung cancer.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center